Cautionary tales in the use of magnets for the treatment of long gap esophageal atresia.


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 22 09 2021
revised: 24 10 2021
accepted: 05 11 2021
pubmed: 9 12 2021
medline: 15 9 2022
entrez: 8 12 2021
Statut: ppublish

Résumé

The use of magnets for the treatment of long gap esophageal atresia or "magnamosis" is associated with increased incidence of anastomotic strictures; however, little has been reported on other complications that may provide insight into refining selection criteria for appropriate use. A single institution, retrospective review identified three cases referred for treatment after attempted magnamosis with significant complications. Their presentation, imaging, management, and outcomes were reviewed. All three patients had prior cervical or thoracic surgery to close a tracheoesophageal fistula prior to magnamosis, creating scar tissue that can prevent magnet induced esophageal movement, leading to either magnets not attracting enough or erosion into surrounding structures. Two patients had a reported four centimeter esophageal gap prior to attempted magnamosis, both failing to achieve esophageal anastomosis, suggesting that these gaps were either measured on tension with variability in gap measurement technique, or that the esophageal segments were fixed in position from scar tissue and unable to elongate. One patient had severe tracheobronchomalacia requiring tracheostomy, with improvement in his airway after eventual tracheobronchopexies, highlighting that magnamosis does not address comorbidities often associated with this patient population. We propose the following inclusion criteria and considerations for magnamosis: an esophageal gap truly less than four centimeters off tension with standardized measurement across centers, cautious use with a history of prior thoracic or cervical esophageal surgery, no associated tracheobronchomalacia or great vessel anomaly that would benefit from concurrent repair, and ideally to be used in centers equipped to manage potential complications. Level IV treatment study.

Sections du résumé

BACKGROUND BACKGROUND
The use of magnets for the treatment of long gap esophageal atresia or "magnamosis" is associated with increased incidence of anastomotic strictures; however, little has been reported on other complications that may provide insight into refining selection criteria for appropriate use.
METHODS METHODS
A single institution, retrospective review identified three cases referred for treatment after attempted magnamosis with significant complications. Their presentation, imaging, management, and outcomes were reviewed.
RESULTS RESULTS
All three patients had prior cervical or thoracic surgery to close a tracheoesophageal fistula prior to magnamosis, creating scar tissue that can prevent magnet induced esophageal movement, leading to either magnets not attracting enough or erosion into surrounding structures. Two patients had a reported four centimeter esophageal gap prior to attempted magnamosis, both failing to achieve esophageal anastomosis, suggesting that these gaps were either measured on tension with variability in gap measurement technique, or that the esophageal segments were fixed in position from scar tissue and unable to elongate. One patient had severe tracheobronchomalacia requiring tracheostomy, with improvement in his airway after eventual tracheobronchopexies, highlighting that magnamosis does not address comorbidities often associated with this patient population.
CONCLUSIONS CONCLUSIONS
We propose the following inclusion criteria and considerations for magnamosis: an esophageal gap truly less than four centimeters off tension with standardized measurement across centers, cautious use with a history of prior thoracic or cervical esophageal surgery, no associated tracheobronchomalacia or great vessel anomaly that would benefit from concurrent repair, and ideally to be used in centers equipped to manage potential complications.
LEVEL OF EVIDENCE METHODS
Level IV treatment study.

Identifiants

pubmed: 34876292
pii: S0022-3468(21)00778-8
doi: 10.1016/j.jpedsurg.2021.11.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

342-347

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Auteurs

Hester F Shieh (HF)

Department of Surgery, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, United States; Department of Surgery, Johns Hopkins All Children's Hospital, 501 6th Ave S, Saint Petersburg, FL 33701, United States.

Russell W Jennings (RW)

Department of Surgery, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, United States.

Michael A Manfredi (MA)

Department of Gastroenterology, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, United States.

Peter D Ngo (PD)

Department of Gastroenterology, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, United States.

Benjamin Zendejas (B)

Department of Surgery, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, United States.

Thomas E Hamilton (TE)

Department of Surgery, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, United States. Electronic address: thomas.hamilton@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH